Koselugo (selumetinib) approved in US for paediatric patients with neurofibromatosis type 1…
AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced that the US Food and Drug Administration (FDA) has approved the…
Read More...
Read More...
